Meet the 2018 Laureates: Gregory Steinberg, PhD

Steinberg, Gregory

Richard E. Weitzman Outstanding Early Career Investigator Award

Gregory Steinberg, PhD

Gregory Steinberg’s research has studied the fundamental mechanism by which energy sensing, endocrine factors, and commonly used medications regulate metabolism. During his PhD, he studied adipocyte-muscle communication and the development of skeletal muscle leptin resistance in obesity. His postdoctoral research extended these findings by identifying that inflammation could impair lipid metabolism in muscle and how the Il-6 family of cytokines can increase fatty acid metabolism and insulin sensitivity.

Upon establishing his own laboratory, his research group identified that skeletal muscle AMP-activated protein kinase (AMPK) was essential for maintaining exercise capacity and for mediating the effects of muscle contractions on glucose uptake, helping to explain how exercise lowers blood sugar in people with type 2 diabetes. His work in muscle also described the molecular underpinnings of the glucose-alanine cycle by showing that during prolonged fasting AMPK is required for the induction of autophagy and the breakdown of the gluconeogenic substrate alanine.

Collectively, Dr. Steinberg’s work has established new paradigms by which energy-sensing mechanisms and endocrine factors regulate multiple branches of metabolism. These findings have important implications for many chronic diseases including obesity, type 2 diabetes, and cardiovascular disease.

His research has extended beyond muscle to establish a vital role for lipid metabolism in regulating macrophage inflammation and for mediating the beneficial effects of salicylate-based drugs, findings that have important implications across many different disease conditions. Subsequent studies from his laboratory established that metformin improves insulin sensitivity through inhibition of liver lipogenesis and that importantly this effect can be enhanced when combined with salicylate. More recently, work in brown and beige adipose tissue has described that AMPK is vital for maintaining mitochondrial quality and that peripheral serotonin is an important endocrine factor that inhibits thermogenesis in obesity and type 2 diabetes.

Collectively, Dr. Steinberg’s work has established new paradigms by which energy-sensing mechanisms and endocrine factors regulate multiple branches of metabolism. These findings have important implications for many chronic diseases including obesity, type 2 diabetes, and cardiovascular disease.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…